Charles Makin

Company: Boehringer Ingelheim

Job title: Head of Real World Evidence & Epidemiology

Seminars:

Examining Real-World Persistence & Adherence to GLP-1s to Inform Payers & Improve Coverage 9:00 am

Uncovering data-driven insights into actual patient behavior with GLP-1 therapies, highlighting factors influencing adherence and persistence beyond clinical trial settings, to demonstrate the practical challenges and opportunities for improved patient management Showcasing how real-world data can be used to assess the long-term economic impact of GLP-1s, aiding payers in value-based purchasing negotiations and demonstrating the financial benefits of sustained…Read more

day: Conference Day One